EP1173746A1 - Appareil et procede de determination des caracteristiques d'un tissu - Google Patents

Appareil et procede de determination des caracteristiques d'un tissu

Info

Publication number
EP1173746A1
EP1173746A1 EP00917869A EP00917869A EP1173746A1 EP 1173746 A1 EP1173746 A1 EP 1173746A1 EP 00917869 A EP00917869 A EP 00917869A EP 00917869 A EP00917869 A EP 00917869A EP 1173746 A1 EP1173746 A1 EP 1173746A1
Authority
EP
European Patent Office
Prior art keywords
interrogation
inner core
probe head
target material
instrument according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00917869A
Other languages
German (de)
English (en)
Other versions
EP1173746A4 (fr
Inventor
Glen Steven Arche
Shabbir B. Bambot
David Farquhar
Mark L. Faupel
Tim Harrell
Walter R. Sanders
Edward L. Kimbrell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spectrx Inc
Original Assignee
Spectrx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1999/010947 external-priority patent/WO1999060377A1/fr
Application filed by Spectrx Inc filed Critical Spectrx Inc
Publication of EP1173746A1 publication Critical patent/EP1173746A1/fr
Publication of EP1173746A4 publication Critical patent/EP1173746A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • G01N21/4738Diffuse reflection, e.g. also for testing fluids, fibrous materials
    • G01N21/474Details of optical heads therefor, e.g. using optical fibres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6843Monitoring or controlling sensor contact pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/16Details of sensor housings or probes; Details of structural supports for sensors
    • A61B2562/164Details of sensor housings or probes; Details of structural supports for sensors the sensor is mounted in or on a conformable substrate or carrier
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0091Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for mammography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/43Detecting, measuring or recording for evaluating the reproductive systems
    • A61B5/4306Detecting, measuring or recording for evaluating the reproductive systems for evaluating the female reproductive systems, e.g. gynaecological evaluations
    • A61B5/4312Breast evaluation or disorder diagnosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/444Evaluating skin marks, e.g. mole, nevi, tumour, scar
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/21Polarisation-affecting properties
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • G01N21/49Scattering, i.e. diffuse reflection within a body or fluid
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence

Definitions

  • the invention is related to apparatus and methods for determining characteristics of a target tissue of a patient.
  • U.S. Patent No. 4,718,417 to Kittrell et al. discloses a method for diagnosing the type of tissue within an artery, wherein a catheter is inserted into an artery and excitation light at particular wavelengths is used to illuminate the interior wall of the artery. Material or tissue within the artery wall emits fluorescent radiation in response to the excitation light.
  • a detector detects the fluorescent radiation and analyzes the amplitudes and wavelengths ofthe emitted fluorescent radiation to determine whether the illuminated portion of the artery wall is normal, or covered with plaque.
  • the contents of U.S. Patent No. 4,718,417 are hereby incorporated by reference.
  • U.S. Patent No. 4,930,516 to Alfano et al. discloses a method for detecting cancerous tissue, wherein a tissue sample is illuminated with excitation light at a first wavelength, and fluorescent radiation emitted in response to the excitation light is detected. The wavelength and amplitude of the emitted fluorescent radiation are then examined to determine whether the tissue sample is cancerous or normal.
  • Normal tissue will typically have amplitude peaks at certain known wavelengths, whereas cancerous tissue will have amplitude peaks at different wavelengths. Alternatively, the spectral amplitude of normal tissue will differ from cancerous tissue at the same wavelength.
  • the disclosure of U.S. Patent No. 4,930,516 is hereby incorporated by reference.
  • a very short burst of excitation light is directed at a target tissue, and fluorescent emissions from the target tissue are then sensed with a detector.
  • the amplitude of the fluorescent emissions are recorded, over time, as the fluorescent emissions decay.
  • the fluorescent emissions may be sensed at specific wavelengths, or over a range of wavelengths.
  • the amplitude decay profile, as a function of time, is then examined to determine a property or condition of the target tissue. For instance,
  • U.S. Patent No. 5,562,100 to Kittrell et al. discloses a method of determining tissue characteristics that includes illuminating a target tissue with a short pulse of excitation radiation at a particular wavelength, and detecting fluorescent radiation emitted by the target tissue in response to the excitation radiation. In this method, the amplitude of the emitted radiation is recorded, over time, as the emission decays. The amplitude profile is then used to determine characteristics of the target tissue.
  • U.S. Patent No. 5,467,767 to Alfano et al. also discloses a method of determining whether a tissue sample includes cancerous cells, wherein the amplitude decay profile of fluorescent emissions are examined. The contents of U.S. Patents Nos. 5,562,100 and 5,467,767 are hereby incorporated by reference.
  • U.S. Patent No. 5,624,847 to Lakowicz et al. discloses a method for determining the presence or concentration of various substances using a phase shift method.
  • U.S. Patent No. 5,515,864 to Zuckerman discloses a method for measuring the concentration of oxygen in blood utilizing a polar anisotropy measurement technique. Each of these methods indirectly measure the lifetime of fluorescent emissions generated in response to excitation radiation.
  • the invention encompasses apparatus and methods for determining characteristics of target tissues within or at the surface of a patient's body, wherein excitation electromagnetic radiation is used to illuminate a target tissue and electromagnetic radiation returned from the target tissue is analyzed to determine the characteristics of the target tissue.
  • Some apparatus and methods embodying the invention can be used to perform a diagnosis at or slightly below the surface of a patient's tissues. For instance, methods and apparatus embodying the invention could be used to diagnose the condition of a patient's skin, the lining of natural body lumens such as the gastrointestinal tract, or the surfaces of body organs or blood vessels.
  • Embodiments of the invention are particularly well suited to analyzing epithelial tissue.
  • Other apparatus and methods embodying the invention can be used to perform a diagnosis deep within a patient's body tissues where the excitation radiation has to pass through several centimeters of tissue before it interacts with the target tissue, such as in diagnosis of tumors and lesions deep in a patient's breast.
  • the returned electromagnetic radiation can comprise electromagnetic radiation that is scattered or reflected from or transmitted through the target tissue. Analysis of the scattered, reflected or transmitted excitation radiation gives a measure of absorption and scattering characteristics of the target tissue. This information can be used by itself to provide a diagnosis, or the information can be used in conjunction with the results of fluorescent emission measurements, as discussed below, to arrive at a more accurate measurement.
  • the reflected or scattered excitation radiation can be measured using intensity based techniques, phase shift techniques, or polarization anisotropy based techniques. While polarization preserving fiber optics are not currently available, should they be developed in the future, polar anisotropic techniques could also be used.
  • the returned electromagnetic radiation can also comprise only fluorescent emissions from the target tissue that are caused by the excitation electromagnetic radiation.
  • apparatus or methods embodying the invention would measure the lifetime or decay time of the fluorescent emissions and use this information to determine characteristics ofthe target tissue.
  • the fluorescent emissions may be generated by endogenous or exogenous fluorescent materials in the target tissue. Both phase shift and polar anisotropy techniques could be used to perform these types of measurements.
  • a device or method embodying the invention can be used to determine the conditions of multiple portions of a target tissue, and the determined conditions can be used to create a map of the target tissue. Such a map could then be either displayed on a display screen, or presented in hard copy format.
  • An instrument embodying present invention could be in the form of an endoscope designed to be introduced into a natural lumen or a cavity of a patient's body.
  • the instrument might be in the form of a catheter designed to be introduced into blood vessels of a patient's body.
  • the apparatus could include means for delivering a therapeutic pulse of electromagnetic radiation to the target tissue.
  • the device could also include means for delivering a therapeutic dose of medication to the target tissue.
  • the instrument could include means for sampling the target tissue depending upon the determined condition of the target tissue.
  • An apparatus embodying the invention that is well suited to developing a map of target tissue conditions may include a plurality of optical fibers that are arranged in a predetermined pattern on the face of a test instrument.
  • Each optical fiber would be capable of delivering excitation radiation and conducting return radiation to a detector.
  • each detection position on the face of the instrument could include at least one optical fiber for delivering excitation radiation and at least one separate fiber for receiving returned radiation.
  • multiple fibers could be used at each position for the excitation or return radiation, or both.
  • An apparatus as described above could also be configured so that once a first set of measurements are taken with the instrument, the locations of the optical fibers could be moved incrementally, and a second set of measurements could be recorded. This could be done by repositioning the instrument face, or by keeping the instrument face stationary, and repositioning the optical fibers behind the instrument face. This process could be repeated several times to obtain multiple sets of readings from the target tissue. The additional sets of measurements could be taken on the same area as the first set, or at different locations on the target tissue.
  • An instrument as described above could be configured to allow rotation of the optical fibers between a plurality of predetermined rotational positions.
  • One embodiment could be configured so that the optical fibers are located at a series of unique positions as the optical fibers are rotated between the predetermined rotational positions. This would allow the device to capture multiple readings at a large number of unique positions on the target tissue. Such a multiple cycle measurement process would allow the optical fibers to be spaced far enough apart to reduce or eliminate cross-talk, while still providing greater resolution than would be possible with a single measurement cycle.
  • An instrument for determining characteristics of a target material could include a probe face configured to conform to a non-uniform and/or non-planar surface area of a target material.
  • the probe face could be shaped to conform to a non-uniform surface area of a target material.
  • the probe body could be a fused glass cane, where one end of the fused cane is shaped to conform to a non-uniform surface area of a target material.
  • the probe body could be attached to a flexible bundle of optic fibers.
  • the instrument could comprise an outer housing, an inner core and a probe face attached to the inner core and comprising a plurality of interrogation devices arranged in a predetermined pattern.
  • the instrument could include an inner core that is rotatably mounted within the housing, where the probe face is mounted on the inner core.
  • the inner core could comprise a first inner core and a second inner core.
  • the second inner core would preferably be configured to slide axially inside the first inner core and rotate with the first inner core when the first inner core is rotated.
  • the probe face would preferably comprise first and second probe faces.
  • the first probe face would preferably be attached to the first inner core and have a centrally located opening for allowing the second inner core to axially slide with respect to the first inner core such that the second probe face is not located in the same plane as the first probe face.
  • a plurality of interrogation devices may be spring-loaded in the probe face so that the plurality of interrogation devices collectively conform to a non-uniform surface area of a target material.
  • each of the plurality of interrogation devices comprises a hollow shaft within which the respective interrogation device is axially movably disposed, the hollow shaft being positioned in the probe face.
  • a spring disposed within the hollow shaft would allow the interrogation device to move axially within the hollow shaft to allow the interrogation devices to collectively conform to a non-uniform surface area of a target material.
  • the plurality of interrogation devices may comprise a plurality of optical fibers.
  • the device could include a detector array, such as a CCD.
  • Light scattered from or generated by a target material could be conducted to the detector array by at least some of the optical fibers.
  • any ofthe above discussed instruments may include a flexible sheath configured to cover and conform to the shape of the probe face.
  • the flexible sheath is preferably optically clear, optically uniform, disposable, and formed of a material having a low durometer and high tear strength.
  • an index matching agent may be located between the flexible sheath and the plurality of interrogation devices.
  • a method of detecting characteristics of a target material preferably comprises positioning a plurality of interrogation devices that are arranged in a pattern adjacent a first plurality of interrogation positions on a non- uniform surface area of a target material so that the plurality of interrogation devices conform to the non-uniform surface area, and detecting characteristics of the target material at the first plurality of interrogation positions.
  • the method may further comprise repositioning the plurality of interrogation devices so that they are adjacent at least one additional plurality of interrogation positions on the target material, and detecting characteristics of the target material at the at least one additional plurality of interrogation positions.
  • the first and at least one additional plurality of positions are not coincident.
  • the repositioning step may comprise rotating the plurality of interrogation devices around a common axis.
  • the method could further include steps of withdrawing the probe from the target material before conducting the rotation step, and then advancing the probe back into contact with the target material after the rotation has been accomplished.
  • Each detecting step may comprise detecting a first type of characteristics of the target material at a plurality of interrogation positions, and detecting a second type of characteristics of the target material at the same plurality of interrogation positions.
  • the first type of characteristics may comprise scattering characteristics
  • the second type of characteristics may comprise fluorescent characteristics.
  • Figure 1 is a cross-sectional view of a device embodying the invention
  • Figures 2A and 2B are cross sectional views of the device shown in Figure 1 taken along section line 2-2
  • Figure 3 is a diagram showing the pattern of interrogation points of a device embodying the invention
  • Figure 4 is another diagram showing the pattern of interrogation points of a device embodying the invention
  • Figure 5 is yet another diagram showing the pattern of interrogation points of a device embodying the invention.
  • FIG. 6 is a block diagram of a device embodying the invention.
  • Figure 7 is a cross-sectional view of a fiber optic probe according to another embodiment of the invention
  • Figure 8 A is a cross-sectional view of the device of Figure 7 taken along section line 8-8;
  • Figure 8B is a diagram of the face of the fiber optic probe of Figure 7;
  • Figure 9 is a front view of a stopper of a slide mechanism according to the invention.
  • Figure 10 is an exploded perspective of a fiber optic probe according to another embodiment of the invention.
  • Figure 11 is a perspective view of the device of Figure 10 after assembly
  • Figures 12 and 13 are schematic diagrams of the face of the fiber optic probe of Figure 11 showing exemplary positions of the optic fibers;
  • Figure 14 shows the general layout of an entire fiber optic probe of Figure 11 in block diagram form;
  • Figure 15 is a partial side view of the fiber optic head of the device of Figure 11;
  • Figure 16A is a partial side view of the probe face of the device of Figure 11;
  • Figure 16B shows an individual spring-loaded optic fiber according to the invention
  • Figure 17 is a diagram of a fused fiber optic probe head
  • Figure 18 is a diagram of a shaped fused fiber optic probe head according to the invention.
  • Figure 19 is a perspective view of a fiber optic probe according to another embodiment of the invention.
  • Figure 20 is a schematic diagram showing exemplary positioning of the optic fibers of the device of Figure 19;
  • Figure 21 is a perspective view of a fiber optic probe according to another embodiment of the invention.
  • Figure 22 is a perspective view of another fiber optic probe according to another embodiment of the invention.
  • Figure 23 is a schematic diagram showing exemplary positioning of the optic fibers of the device of Figure 21;
  • Figure 24 is a side view of the device of Figure 21;
  • Figure 25 is a front view of the device of Figure 21.
  • Figure 26 is a side view of the device of Figure 22.
  • the invention is primarily concerned with devices which are used to take measurements on a target material or tissue.
  • Devices embodying the invention are capable of conforming to nonplaner tissue so that accurate spectroscopic based measurements can be taken.
  • Devices and method embodying the invention can utilize a wide range of different spectroscopic interrogation techniques to detect or diagnose the condition of a target material or tissue.
  • a device embodying the invention could be configured to take reflectance or scattering measurements, or measurements of fluorescence produced by a target material or tissue.
  • the fluorescence measurements could include measurements of the amplitude of particular wavelengths, or measurements of the lifetime of a fluorescent emission.
  • a scattering measurement, or a fluorescence measurement could be conducted using phase shift or a polarization anisotropic method.
  • an interrogation device such as a probe
  • the probe face in contact with the target material or tissue would extend across an area of the target material or tissue to be interrogated.
  • Multiple measurements would be made at a plurality of different locations on the area contacted by the probe face. Ideally, the plurality of measurements would be made substantially simultaneously at all the plurality of interrogation points on the target material or tissue.
  • excitation electromagnetic radiation would be delivered to a plurality of different locations on a target material or tissue using a plurality of optical fibers.
  • the electromagnetic radiation could be in the visible light range, or in the infrared or ultraviolet light ranges.
  • the term "light” will be used to refer to any wavelength of electromagnetic radiation that is delivered to target material or tissue for purposes of conducting a spectroscopic measurement.
  • a device and method embodying the invention could then include collecting light that is scattered or reflected from the target material or tissue at each of the plurality of interrogation points.
  • the light could be collected using a plurality of optical fibers.
  • a device or method embodying the invention could collect fluorescent light, which is produced by the target material or tissue in response to the excitation light.
  • spectroscopic analyses could be performed using the collected scattered or fluorescent light.
  • the inventors contemplate that a device embodying the invention could be used to conduct measurements on many different types of materials.
  • a device embodying the invention could also be utilized to determine the status or condition of a target tissue on a human or animal patient.
  • a probe embodying the invention could be configured to contact the skin of a patient or a device could be configured to contact a target tissue area inside the body of a patient.
  • endoscopes, catheters, and other probing devices embodying the invention could be used to bring an interrogating probe face into contact with a target tissue inside the body of a patient.
  • One of the most difficult problems with in vivo tissue diagnostics and disease measurement is the biological diversity of normal tissue properties between different patients, or even within the same patient. Furthermore, this diversity is time variant both in the long term and in the short term. Long term variations may be due to patient age, hormonal milieu, metabolism, mucosal viscosity, and circulatory and nervous system differences. Short term variations may be from blood perfusion changes due to heart beat, physical movement, local temperature changes, etc.
  • a target tissue Because of the variability of tissue characteristics, to accurately determine whether a target tissue is diseased, it is helpful to compare measurements of a suspect target tissue to measurements of normal tissues from the same patient. If possible, the measurements of the known normal tissue should be made concurrently or simultaneously with the measurements of the suspect target tissue. The normal tissue measurements then serve as a baseline for normalcy, variations from which may be interpreted as disease. To arrive at a baseline measurement, a number of strategies can be used. First, visual characteristics such as pigmentations (nevi) in skin, or polyps in the colon, can be used to identify potentially abnormal regions. Normalized or averaged spectra of multiple regions surrounding these potentially abnormal, visually distinct regions can be used to establish baseline measurements. The baseline measurements can then be compared to measurements taken on the abnormal, visually distinct regions. Measurements of normal and abnormal regions based on visual characteristics could be automated using imaging capabilities of the measurement device itself.
  • measurements can be taken on spaced apart regions along a portion of a lumen or tissue. The spacing between the regions would be dependent on the type of tissue being diagnosed. Then, differentials between individual measurements taken at different regions would be calculated. If a differential for one area of a target tissue, relative to the surrounding tissue, exceeds a preset amount, the tissue area would be diagnosed as diseased.
  • a gradient in spectral response as one moves away from a visually suspicious site could also be used as a marker for disease. This is easily automated and can be implemented effectively in any imaging modality.
  • pattern recognition algorithms e.g., neural nets
  • neural nets could also be used to analyze differences in readings taken from various sites in the same patient or from multiple readings from different patients.
  • a first device embodying the invention that can be used to determine tissue characteristics is shown, in longitudinal cross-section, in Figure 1.
  • the instrument 110 includes a cylindrical outer housing 112 with a circular end cap 120 configured to abut the target tissue.
  • a rotating cylindrical inner core 114 is mounted in the outer housing 112.
  • a bundle of optical fibers 116 are located inside the inner core 114.
  • the optical fibers 116 pass down the length of the inner core 114 and are arranged in a specific pattern at the end adjacent the end cap 120 of the outer housing 112.
  • the end of the inner core 114 adjacent the end cap 120 is mounted within the outer housing 112 with a rotating bearing 122.
  • the end cap 120 is at least partially transparent or transmissive so that electromagnetic radiation can pass from the optical fibers, through the end cap, to illuminate a target tissue adjacent the end cap 120. Light scattered from or generated by the target tissue would then pass back through the end cap 120 and back down the optical fibers 116.
  • the inner core 114 is also mounted inside the outer housing 112 by a detent mechanism 118.
  • the detent mechanism is intended to support the inner core 114, and ensure that the inner core is rotatable within the outer housing 112 by predetermined angular amounts.
  • a cross sectional view ofthe instrument shown in Figure 1, taken along section line 2-2 of Figure 1, is shown in Figure 2 A.
  • the inner core 114 is supported within the outer housing 112 by the detent mechanism.
  • the detent mechanism includes two mounts 134 with spring loaded fingers 136 that are biased away from the inner core 114.
  • the detent mechanism also includes four stoppers 130, each of which has a central depression 132.
  • the spring loaded fingers 136 are configured to engage the central depressions 132 of the stoppers 130 to cause the rotatable inner core to come to rest at predetermined angular rotational positions.
  • four stoppers are provided in the inner surface of the outer housing 112.
  • the inner core 114 will be rotatable in increments of
  • FIG. 2B An alternate embodiment of the detent mechanism is shown in Figure 2B.
  • six stoppers 130 are spaced around the inside of the outer housing 112.
  • Three mounts 134, each having its own spring loaded finger 136, are mounted on the inner core 114.
  • the three mounts 134 are spaced around the exterior of the inner core 114 approximately 120° apart. This embodiment will allow the inner core to be rotated to predetermined positions in increments of 60°.
  • the location of the three mounts, 120° apart helps to keep the inner core 114 supported in the center of the outer housing 112.
  • the ends of the optical fibers may be mounted on a circular end plate 121 that holds the optical fibers in a predetermined pattern.
  • the circular end plate 121 would be rigidly attached to the end of the cylindrical inner core 114.
  • an index matching agent 123 may be located between the end plate 121 and the end cap 120 on the outer housing 112. The index matching agent 123 can serve as both an optical index matching agent, and as a lubricant to allow free rotation of the end plate 121 relative to the end cap 120.
  • FIG. 3 A diagram showing how the optical fibers are positioned on the face of an embodiment of the instrument is shown in Figure 3.
  • the face of the instrument which would be the end cap 120 of the device shown in Figure 1, is indicated by reference number 140 in Figure 3.
  • the black circles 142 represent the locations of optical fibers behind the end cap 120.
  • the hollow circles 144 represent the positions that the optical fibers will move to if the inner core 114 of the instrument is rotated 90°. Thus, each of the circles represent positions that can be interrogated with the optical fibers.
  • a single optical fiber will be located at each of the positions shown by the black circles 142 in Figure 3.
  • excitation light would travel down the fiber and be emitted at each interrogation position indicated by a black circle 142.
  • Light scattered from or produced by the target tissue would travel back up the same fibers to a detector or detector array.
  • pairs of optical fibers could be located at each position indicated by a black circle 142.
  • one optical fiber of each pair would conduct excitation light to the target tissue, and the second optical fiber of each pair would conduct light scattered from or generated by the target tissue to a detector.
  • multiple fibers for carrying excitation light and/or multiple fibers for carrying light scattered from or generated by the target tissue could be located at each interrogation position indicated by a black circle 142.
  • the instrument would first be positioned so that the end cap 120 is adjacent the target tissue.
  • the end cap 120 may be in contact with the target tissue, or it might be spaced from the surface of the target tissue.
  • an index matching material may be interposed between the end cap and that target tissue.
  • the optical fibers would be used during a first measurement cycle to simultaneously measure tissue characteristics at each of the interrogation positions in Figure 3 having a black circle 142.
  • the tissue characteristics could be measured using any of the measurement techniques discussed above.
  • the inner core 114 would be rotated 90° within the outer housing 112, and the optical fibers would be used during a second measurement cycle to simultaneously measure tissue characteristics at each of the interrogation positions in Figure 3 having a hollow circle 144.
  • Cross-talk can also occur if excitation light from a first interrogation position travels through the target tissue and enters an adjacent interrogation position.
  • One of the easiest ways to reduce or eliminate cross-talk is to space the interrogation positions farther apart. However, increasing the spacing between interrogation positions will reduce the resolution ofthe device.
  • An instrument embodying the present invention with a rotatable inner core, allows the interrogation positions to be spaced far enough apart to reduce or substantially eliminate cross-talk, while still obtaining excellent resolution.
  • good resolution is obtained without the negative impact to sensitivity or selectivity caused by cross-talk.
  • fewer optical fibers and fewer corresponding detectors are required to obtain a given resolution.
  • the ability to obtain a plurality of tissue measurements simultaneously from positions spaced across the entire target tissue has other benefits.
  • tissue characteristics can vary significantly from person to person, and the tissue characteristics can vary significantly over relatively short periods of time.
  • the most effective, way to determine the locations of diseased areas is to establish a baseline for normal tissue, then compare the measurement results for each interrogation point to the baseline measurement.
  • the easiest way to determine the location of a diseased area is to simply look for a measurement aberration or variance. Because tissue characteristics can change relatively quickly, in order to establish accurate, clearly defined variances between tissue characteristics, it is desirable to take a plurality of readings simultaneously over as large an area as possible.
  • the resolution of the device is preferably approximately 1 mm, or less.
  • the spacing between interrogation positions should be approximately 1 mm, or less.
  • An instrument embodying the present invention allows the interrogation positions to be spaced sufficiently far apart to essentially eliminate cross-talk, while still obtaining the requisite approximately 1 mm resolution.
  • results from each measurement cycle can be used to detect variances in tissue characteristics that help to localize diseased areas.
  • an instrument embodying the present invention balances the competing design requirements of resolution, elimination of cross-talk, and the desire to make all measurements simultaneously to ensure that time- varying tissue characteristics are taken into account.
  • FIG. 4 A second arrangement for the optical fibers of a device as shown in Figure 1 is depicted in Figure 4.
  • the interrogation positions are arranged in a hexagonal honeycomb pattern.
  • the black circles 142 indicate the positions that would be occupied by optical fibers during a first measurement cycle
  • the hollow circles 144 indicate positions that would be occupied by the optical fibers during a second measurement cycle after the inner core 112 has been rotated by 60°.
  • This pattern achieves maximum spacing between adjacent interrogation positions during each measurement cycle, and essentially doubles the resolution of the instrument.
  • FIG. 5 A third arrangement for the optical fibers of a device shown in Figure 1 is depicted in Figure 5.
  • the optical fibers are again arranged according to a hexagonal honeycomb pattern.
  • far fewer optical fibers are used in this embodiment.
  • This third embodiment is intended for use in a measurement process that calls for six measurement cycles. The inner core of the device would be rotated 60° between each measurement cycle. Over the course of the six measurement cycles, the device would ultimately interrogate all the black circled 142 and hollow circled 144 interrogation positions shown in Figure 15. This embodiment allows for even greater separation distances between interrogation positions (to reduce or substantially eliminate cross-talk) while still achieving excellent measurement resolution.
  • far fewer optical fibers and corresponding detectors would be required to achieve a given measurement resolution.
  • the detection fibers had a diameter of approximately 100 mm. Measurements were made on optical reference standards, and tissue. Under these conditions, it was necessary to space the interrogation positions approximately 3 mm apart to substantially eliminate cross-talk. Thus, if an instrument were not designed as described above, so that the inner core can rotate the interrogation positions to different locations on the target tissue, the device would only be capable of achieving a resolution of approximately 3 mm.
  • the measurements involve three measurement dimensions, two dimensions for the area of the target tissue, and a third dimension comprising the spectral information.
  • a device capable of conducting measurements in these three dimensions is shown in Figure 6.
  • the instrument includes a light source 20, and a filter assembly 22.
  • a plurality of excitation optical fibers 116a lead from the filter assembly 22 to the target tissue 50.
  • a plurality of detection fibers 116b lead away from the target tissue 50.
  • the excitation optical fibers 116a and the detection optical fibers 116b are arranged in pairs as described above.
  • the light source 20 and filter assembly 22 allow specific wavelengths of light to be used to illuminate the target tissue 50 via the excitation optical fibers 116a.
  • the filter assembly 22 could be a single band pass optical filter, or multiple optical filters that can be selectively placed between the light source 20 and the excitation optical fibers 116a.
  • the filter assembly 22 could comprise an electrically switchable color filter which can selectively pass/block specific wavelength bands of light in response to electrical control signals.
  • the light source 20 and filter assembly 22 could be replaced with a wavelength tunable light source.
  • a plurality of light sources, such as lasers could be used to selectively output specific wavelengths or wavelength bands of excitation light.
  • the detection fibers lead to an optical system 55.
  • the light from the detection fibers 116b passes through the optical system and into a detector array 56.
  • the detector array may comprise a plurality of photosensitive detectors, or one or more spectrophotometers.
  • the detector array 56 is preferably able to obtain measurement results for each of the detection fibers 116b simultaneously.
  • the optical system 55 can include a plurality of optical filters that allow the detector array to determine the intensity of light at certain predetermined wavelengths or wavelength bands.
  • the detector array would be a two dimensional array of photosensitive detectors, such as a charge coupled device (CCD).
  • CCD charge coupled device
  • the optical system 55 would comprise a spectrograph that is configured to separate the light from each detection optical fiber 116b into a plurality of different wavelengths, and to focus the different wavelengths across several pixels on the CCD. Thus, a group of pixels on the CCD would correspond to a single detection fiber.
  • the intensities of the different wavelengths of light carried by a single detection fiber 116b could be determined based on the outputs of a plurality of individual pixels of the CCD.
  • a device may be configured so that a portion of a plurality of optical fibers of a fiber optic probe are telescopically mounted.
  • FIG 7. An example of such a periscoping fiber optic probe according to the invention is shown in Figure 7.
  • the instrument 210 includes a cylindrical outer housing 212.
  • a cylindrical rotating inner core 214A is mounted in the outer housing 212.
  • a bundle of optical fibers 216A are located inside the rotating inner core 214A.
  • a cylindrical periscoping inner core 214B is mounted within the rotating inner core 214 A.
  • the periscoping inner core 214B is mounted so that it can move axially with respect to the rotating inner core 214 A.
  • the periscoping inner core 214B would rotate with the rotating inner core 214 A.
  • the optical fibers 216A, 216B pass down the length of the inner cores 214A, 214B, respectively, and are arranged in a specific pattern at the end adjacent an end cap 220 of the outer housing 212.
  • the end of the rotating inner core 214A is mounted within the outer housing with a rotating bearing 222.
  • the end cap 220 is flexible and at least partially transparent or transmissive so that electromagnetic radiation can pass from the optical fibers, through the end cap 220, to illuminate a target tissue adjacent the end cap 220. Light scattered from or generated by the target tissue would then pass back through the end cap 220 and back down the optical fibers 216A, 216B.
  • FIG. 8 A A cross-sectional view of the device of Figure 7, taken along section line 8-8, is shown in Figure 8 A.
  • the periscoping inner core 214B is mounted inside the rotating inner core 214A by a slide mechanism which allows the periscoping inner core 214B to slide axially with respect to the rotating inner core 214A but rotate with the rotating inner core 214A when it rotates.
  • a slide mechanism which allows the periscoping inner core 214B to slide axially with respect to the rotating inner core 214A but rotate with the rotating inner core 214A when it rotates.
  • the mechanism is comprised of fingers 238 A, which fit into grooves 238C of stoppers 238B.
  • the groove 238C extends along most ofthe length ofthe stopper 238B.
  • the stopper 238B is mounted on an inner wall of the rotating inner core 214A.
  • the structure allows the periscoping inner core 214B to slide axially with respect to the rotating inner core 214A. However, when the rotating inner core 214A is rotated, the periscoping inner core 214B rotates along with it. The axial movement of the periscoping inner core 214B is delimited by the length of the groove 238C.
  • other structures could be used in place of the one shown in Figures 8A, 8B and 9.
  • the other structures would also allow one portion of the device to move axially with respect to another part so that an end face of the probe can conform to non-uniform surface areas of a target material.
  • the axially slidable portion may or may not be rotatable with the stationary part.
  • the mechanism may be constructed so that the axially slidable portion can rotate, and the stationary part does not.
  • the rotating inner core 214 A is supported within the outer housing 212 by the detent mechanism 218.
  • the detent mechanism includes three mounts 234 with spring loaded fingers 236 that are biased away from the rotating inner core 214A.
  • the detent mechanism also includes 6 stops 230, each of which has a central depression 232.
  • the spring loaded fingers 236 are configured to engage the central depressions 232 of the stops 230 to cause the rotating inner core 214A to come to rest at predetermined angular rotational positions.
  • the periscoping inner core 214B rotates with the rotating inner core 214A.
  • the ends of the optical fibers are preferably positioned on or adjacent to circular end plates 221 A, 22 IB that hold the optical fibers in a predetermined pattern, as shown in Figure 8B.
  • the circular end plate 221 A preferably includes a centrally located opening for the periscoping inner core 214B.
  • the circular end plates 221 A, 22 IB are preferably rigidly attached to ends ofthe rotating inner core
  • an index matching agent 223 may be located between the end plates 221 A, 22 IB and the end cap 220 on the outer housing 212.
  • the black circles 242 in Figure 8B represent the locations of the optical fibers upon initial positioning of the fiber optic probe adjacent a target material.
  • the optical fibers will move to new positions when the rotating inner core 214 A and periscoping inner core 214B are rotated, similar to the depiction shown in Figure 13, in which the hollow circles represent the positions that the optical fibers will move to upon rotation.
  • a single optical fiber will be located at each of the positions shown by the black circles 242 in Figure 8B.
  • excitation light would travel down the fiber and be emitted at each interrogation position indicated by a black circle 242.
  • Light scattered from or produced by the target tissue would travel back up the same fibers to a detector or detector array.
  • a pair of optical fibers could be located at each interrogation position, where one optical fiber of each pair would conduct excitation light to the target tissue, and the second optical fiber of each pair would conduct light scattered from or generated by the target tissue to a detector.
  • multiple fibers for carrying excitation light and/or multiple fibers for carrying light scattered from or generated by the target tissue could be located at each interrogation position indicated by a black circle 242.
  • the instrument would first be positioned so that the end cap 220 is adjacent the target tissue.
  • the end cap 220 may be in contact with the target tissue, or it might be spaced from the surface of the target tissue.
  • the periscoping inner core 214B would then be axially extended to conform the probe face to the surface of a target tissue, such as, for example, the cervix of a patient.
  • an index matching material may be interposed between the end cap 220 and the target tissue.
  • the optical fibers would be used during a first measurement cycle to simultaneously measure tissue characteristics at each of the interrogation positions shown in Figure 8B having a black circle 242. The tissue characteristics could be measured using any of the measurement techniques previously discussed.
  • the rotating inner core 214A along with the periscoping inner core 214B, would be rotated within the outer housing 212, and the optical fibers would be used during a second measurement cycle to simultaneously measure tissue characteristics at each of another set of interrogation positions.
  • the periscoping inner core 214B would be withdrawn before the assembly is rotated. Afer rotation, the periscoping inner core 214B would be extended back out so that the probe face conforms to the target tissue.
  • 221 A, 22 IB may have shapes that allow the face of the probe to better conform to a non-uniform target material. Some examples of suitable shapes are discussed below in conjunction with different embodiments of the invention.
  • an instrument as shown in Figures 7, 8A and 8B helps to balance the competing design requirements of resolution, elimination of cross-talk, and a desire to make a plurality of measurements simultaneously at multiple interrogation locations across the surface of the target tissue. Further, as discussed above, by capturing a plurality of measurements at different locations across the surface of the target tissue, one is better able to detect the presence of diseased tissue by comparing the diseased areas to normal tissue which is measured at the same time.
  • the end cap 220 is a transparent or transmissive optical window or barrier. This barrier serves several purposes including, but not limited to, serving as a sterilizable or single use interface for the protection of the patient; protecting instrument parts from the ingress of bodily fluids; providing a patient contact surface that is benign and free of material related hazards; shielding the patient from possible electrical discharge with metal parts used in the instrument; and providing an optical conduit between the device and patient tissue.
  • the end cap 220 should be flexible enough that it readily conforms to the shape of the tissue surface during measurement. The end cap 220 must also fit tightly over the surface of the probe face.
  • the end cap 220 is preferably flexible and membranelike with a low durometer (i.e., high stretchability) and high tear strength in order to prevent breakage. Further, the end cap 220 is preferably optically clear with a high transmission of wavelengths ranging from approximately 280 nm to approximately 700 nm. The end cap 220 should also be optically uniform across the entire window surface.
  • end cap material is dimethyl silicone, with a preferred durometer of 20 (on shore A scale) and a tear strength of 100 lbs/in. However, other materials may also be appropriate.
  • Figure 10 is an exploded view of the device of Figure 11.
  • the device 310 includes outer casing 312A, 312B, 312C, a mount/handle 312D, and a cover 302 for when the device is not in use.
  • a probe head 304 including a rotatable inner core 314, a probe face 315 and a plurality of fiber optic probe elements
  • the rotatable shaft 361 is supported in a bearing 361A and is rotated by a movement mechanism 303.
  • the movement mechanism 303 could simply rotate the shaft 361 and probe face 315.
  • the movement mechanism could also be configured to move the shaft 361 and probe face 313 axially within the casing 312C.
  • Each fiber optic probe element 317 is spring-loaded and is held within a corresponding cylindrical hole on the probe face 315.
  • Each spring-loaded fiber optic probe element 317 is comprised of a hollow shaft 319, as shown in Figure 16B.
  • Each shaft 319 has an axially extending opening 319A for housing one or more optical fibers
  • a spring 318 can be located below the shaft 319, as shown in Figure 16B, or the spring could surround a lower portion 319C of the shaft 319, as shown in Figure 16A. Because the fiber optic probe elements 317 are each spring-loaded, they can collectively conform to a non-uniform surface area of a target material. Of course, many other options would be available to bias the fiber optic probe elements 317 away from the probe face 315.
  • the probe face 315 is preferably covered with a flexible window or membrane 320, such as the flexible window or membrane previously discussed.
  • the flexible window or membrane 320 must readily conform to the collective positions adopted by the fiber optic probe elements 317 during measurement, that is, the flexible window 320 surface must not hinder the free movement of the pins or substantially impair the "springiness" of the probe elements
  • the flexible window 320 would fit tightly over each probe element 317 as to prevent air gaps from forming between the probe element 317 and the flexible window 320.
  • the probe face 315 In operation, the probe face 315, with its flexible window covering 320, would be pressed against the target tissue to be examined. This would cause at least some of the fiber optic probe elements 317 to be depressed into the face 315 against the bias of the corresponding springs 318. In this manner, the flexible window 320 would conform to an uneven/non-planer surface area of the target tissue. Provided the flexible window 320 has sufficient flexibility, the flexible window 320 should remain in contact with the target tissue regardless of the contours of the target tissue.
  • the fiber optic probe elements 317 are preferably positioned in a uniform geometric pattern over the probe face 313, as shown in Figure 12.
  • the arrangement of the fiber optic probe elements 317 is designed such that by rotating the probe face 315 through a 60° angle the fiber optic probe elements 317 interrogate an equispaced but different set of positions on the target material. By rotating the probe face 315 a total of five times (6 positions), 42 fiber optic elements 317 could be used to interrogate a total of 252 different locations on the target tissue.
  • This scheme is illustrated in Figure 13, where the dark circles 342 represent the original optic fiber probe elements arrangement and the open circles 344 represent the new positions occupied over successive rotations of the probe. In this manner, a large number of points on the tissue are interrogated.
  • the spatial resolution is roughly multiplied 6 fold. Given an approximately 3.4 mm separation between each fiber or fiber pair on the face of the probe, the target material surface is sampled roughly every approximately 1 mm after the probe is rotated through 6 positions.
  • the rotation of the probe face 315 is motorized and automated in order to simplify the measurement procedure.
  • the probe face 315 is at least partially retracted into the outer casing 312C prior to rotation. This helps to prevent the fiber optic probe elements 317 from rubbing against the flexible sheath or window 320 during rotation.
  • the rotation and retraction can be performed by, for example, a linear stepper motor.
  • a suitable single 12V linear stepper motor is made by Haydon Switch and Instrument Inc., in Waterbury, Connecticut, as part no. Z26542-12-004, which combines linear actuation and rotation in a single motion.
  • the stepper motor can be controlled using a driver controller, such as, for example, the driver controller made by API Controls in Amherst, New Jersey as part no. DM 224-IO.
  • the sequence for measuring at each rotation position is as follows.
  • the probe face 315 is first extended out of the casing 312C and is brought adjacent to or in contact with the inner surface ofthe flexible window 320.
  • the probe end would then be brought into contact with the target tissue and the probe end would be pressed against the target tissue so that at least some of the fiber optic probe elements 317 are pushed into the probe face 315 against the springs.
  • Spectral measurements are then made at each ofthe interrogation positions adjacent the fiber optic probe elements 317.
  • the probe head is withdrawn into the casing 312, the probe head is rotated 60°, and the probe head is pushed back into position against the target tissue. This procedure is repeated, as necessary, to interrogate all desired locations on the target material.
  • the uterine cervix for example, has a curved, donut shaped, surface with the endocervical canal located approximately in its center.
  • the sloped area in the center of the cervix leading to the canal would not be accessible to a probe having a planar end face.
  • the Squamo-Columar (SC) junction the area where most disease is found, occurs in this "missed" area.
  • the remaining portions of the surface profile of the cervix varies in depth, slope and shape making a "one size fits all" contoured surface probe unsatisfactory. In addition there are other surface undulations that are patient specific.
  • the patient may have had prior surgical removal of tissue (LEEP or cryosurgery) that would present a non-uniform surface ofthe cervix for measurement.
  • tissue LEEP or cryosurgery
  • An added advantage of such an approach is that a calibrated and constant force pressing the fiber optic probe elements
  • 317 against the tissue can be maintained by designing the device with appropriate spring characteristics.
  • FIG 14 shows the general layout of a fiber optic probe embodying the invention in block diagram form.
  • the fiber optic probe includes a probe ferrule 291, a reference ferrule 293, a lamp ferrule 292 and a spectrograph ferrule 294. All of the collection optic fibers, plus an additional reference fiber, are aligned in a vertical column and placed at the entrance slit of the spectrograph ferrule 294. All of the excitation fibers from the probe and a reference fiber are also arranged in a random tight circle at the lamp ferrule 292. When a measurement is taken using the probe shown in Figure 14, excitation light from the lamp ferrule 292 would illuminate a portion ofthe reference ferrule 293.
  • Light backscattered or reflected from the reference ferrule would be collected by a reference fiber that then travels through the spectrographic ferrule 294.
  • a detector element would be positioned within the spectrograph ferrule 294 to detect the light scattered or reflected from the reference ferrule. A signal from this detector would then be used to calibrate or reference readings coming from the probe ferrule 291.
  • Excitation light would also be sent from the lamp ferrule 291 to the probe ferrule 291.
  • the probe ferrule 291 would be positioned adjacent to the target tissue, and the excitation light would be coupled to the target tissue at the interrogation end of the probe ferrule.
  • Scattered or reflected excitation light, or fluorescent light produced in response to the excitation light would then be coupled back into the probe ferrule 291. This response light would then be conveyed by optical fibers over to the spectrograph ferrule 294. Detectors within the spectrograph ferrule 294 would be used to detect characteristics of the light coming from the target tissue.
  • the probe head 410 is formed of a chunk of glass having a plurality of light conducting passageways 416.
  • a chunk of glass is doped to form two layers, a core surrounded by a cladding, thus forming the basics of an optical passageway 416.
  • the chunk of glass is then heated and drawn out lengthwise, then folded over to double the material, and hence the number of optical passageways 416. This process is repeated multiple times, and each time the material is drawn and folded over, the number of optical passageways 416 is doubled and the individual passageways become thinner. For example, there can be 10,000 optical passageways in an approximately 3.4 mm diameter cane. This process is repeated until the cane or probe head contains the desired number of optical passageways.
  • the individual halves fuse together.
  • one end can be drawn away to form a tapered cane, where one end is thinner than the other.
  • a tapered cane could be used in a probe head to magnify or de-magnify an image of an object. Further, the cane can be twisted to produce a probe head that inverts an image of an object.
  • the end of the cane is cut off perpendicular to the central axis of the cane, which provides a flat image of an object.
  • Some canes may have shaped ends, which can act as a lens, to produce desired optical properties.
  • the present invention comprises using a cane as described above as a probe head, and shaping the end of the probe head, that is, the distal end of the probe head, to compliment the surface of the target material. More particularly, the invention proposes making a non-flat image plane for purposes of analyzing a non-uniform surface area of the target material.
  • the end ofthe fused cane head could be ground and polished using a diamond machine to shape the end according to the geometry of the target material to be interrogated.
  • the end of the cane would be shaped to conform to the geometry of the target material to be probed.
  • Figure 18 is cross-sectional view showing a circular probe head 510 which has been cut across the center.
  • the probe head 510 would be generally circular, and have a conical shape which rises to a point 512 at the center.
  • a plurality of optical passageways 516 similar to the optical fibers, would run from the top to the bottom of the probe head 510.
  • the conical shaped surface 515 of the probe head 510 would be designed to contact a target tissue area to be interrogated.
  • the circular and conical shaped probe head 510 shown in Figure 18 would be suitable for interrogating the cervix of a patient.
  • the flat bottom surface 517 could be interfaced to a detector or imaging device.
  • the bottom surface 517 could be interfaced to another set of flexible optic fibers that lead to a detector or imaging device.
  • a fused optical fiber bundle, or cane, could be used as a low cost way to obtain a shaped probe end which would be interfaced to remaining portions of a spectroscopic interrogation device.
  • an interrogation device capable of analyzing scattered excitation light or fluorescent light generated by a target tissue could be configured to receive any of a plurality of detachable probe heads, formed as shown in Figure 17, or with other shapes that can conform to non-uniform target materials. This would allow a user to select an appropriately shaped probe head which would best conform to the target tissue being interrogated.
  • Figure 19 shows a fiber optic probe end 610 having a face 615 shaped to conform to a non- uniform contour of a target material. This particular configuration allows investigation of the OS and transitional zone of the cervix.
  • a probe end embodying the invention could also have other configurations specifically designed to conform to the contour of other target tissue areas.
  • the outer flat portion 615 A is utilized for interrogating the ectocervix while the inner stepped portion 615B is used for interrogating the OS and endocervical canal.
  • the inner stepped portion 615B can be fixed with respect to the outer flat portions 615A, or the inner stepped portion 615B can be designed to slide axially with respect to the outer flat portions 615A. This would provide flexibility in positioning of the inner portion 615B within the depths of the cervix and would allow the device to conform to the particular patient's anatomy.
  • Figure 20 shows that optic fibers 616 would run from the top surfaces of the probe head 610 down to a rear surface 618.
  • the optical fibers 616 could then run from the rear surface 618 of the probe head 610 onto a detector unit.
  • the optical fibers 616 within the probe head 610 could terminate at the rear surface 618.
  • additional optical fibers could couple to the rear surface 618 so that the optical fibers within the probe heads 610 communicate with an additional set of flexible optical fibers which lead to a detection device.
  • This type of an arrangement could allow a plurality of different probe heads 610 having, different shapes, to be coupled to the same basic interrogation device.
  • Figure 21 shows an additional configuration for a shaped probe head.
  • the shaped probe head 710 of Figure 21 has a flat portion that extends into a central conical portion 715B having a rounded tip.
  • Figure 23 provides a perspective view of this type of probe head.
  • Figure 23 shows an example of how optic fibers 716 can be positioned with respect to the face 715 of the shaped probe 710.
  • Figure 24 is a side view of the shaped probe 710 of Figure 21.
  • Figure 25 is a top view of the shaped probe 710 of Figure 21.
  • the shaped probe head 710 of Figure 21 would be suitable for interrogating the surface of a cervix, since the probe head 710 allows the cervix/OS to conform to the surface of the probe head 710.
  • a protective flexible disposable membrane can also be formed to fit the profile of the probe face.
  • a different shaped probe head 810, shown in Figure 22, has a flat portion 815A, a stepped portion 815C and a central conical portion 815B with a rounded tip.
  • Figure 26 is a side view of the shaped probe of Figure 22.
  • the outer flat portion 815A of the shaped probe of Figure 22 is designed to be used for interrogating the ectocervix, while the central conical portion 815B and stepped portion 815C are used for interrogating the OS and endocervical canal.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

L'appareil de cette invention comprend une tête (137) de sonde dotée d'une surface d'interrogation qui est destinée à être positionnée à coté d'un matériau ou tissu (50) cible ou à être poussée contre celui-ci. La tête (137) de sonde est conçue de manière à posséder une pluralité de dispositifs d'interrogation disposés dans toute la surface d'interrogation, et est également conçue de sorte que le dispositif d'interrogation puisse épouser une surface non uniforme ou non plane du tissu (50) cible. Selon certaines réalisations, la surface d'interrogation peut avoir une forme particulière qui épouse la forme d'un matériau cible. Selon d'autres réalisations, une ou plusieurs parties de la surface d'interrogation pourraient être déplacées par rapport aux autres parties de sorte que la surface d'interrogation puisse épouser une surface non uniforme. Et toujours selon d'autres réalisations, une pluralité de dispositifs d'interrogation, pouvant être déplacés séparément, peuvent être disposés dans la surface d'interrogation. Dans un procédé de mesure, une pression est exercée sur la surface d'interrogation qui vient en contact avec la surface uniforme de manière à déplacer certains dispositifs d'interrogation individuels, la tête de sonde venant ainsi épouser la surface non uniforme.
EP00917869A 1999-03-25 2000-03-24 Appareil et procede de determination des caracteristiques d'un tissu Withdrawn EP1173746A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12606599P 1999-03-25 1999-03-25
US126065P 1999-03-25
WOPCT/US99/10947 1999-05-19
PCT/US1999/010947 WO1999060377A1 (fr) 1998-05-19 1999-05-19 Appareil et procede pour determiner les caracteristiques de tissus
PCT/US2000/006428 WO2000057157A1 (fr) 1999-03-25 2000-03-24 Appareil et procede de determination des caracteristiques d'un tissu

Publications (2)

Publication Number Publication Date
EP1173746A1 true EP1173746A1 (fr) 2002-01-23
EP1173746A4 EP1173746A4 (fr) 2008-04-23

Family

ID=26795573

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00917869A Withdrawn EP1173746A4 (fr) 1999-03-25 2000-03-24 Appareil et procede de determination des caracteristiques d'un tissu

Country Status (3)

Country Link
EP (1) EP1173746A4 (fr)
AU (1) AU3877600A (fr)
WO (1) WO2000057157A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1673007B1 (fr) * 2003-10-03 2016-06-01 Academisch Medisch Centrum bij de Universiteit van Amsterdam Système et méthode de représentation en images de la réflectance d'un substrat
US9131861B2 (en) 2004-11-30 2015-09-15 Academisch Medisch Centrum Pulsed lighting imaging systems and methods

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5125404A (en) * 1985-03-22 1992-06-30 Massachusetts Institute Of Technology Apparatus and method for obtaining spectrally resolved spatial images of tissue
WO1996029926A1 (fr) * 1995-03-31 1996-10-03 The Board Of Regents, The University Of Texas System Sonde destinee a la detection des neoplasies cervicales au moyen de la spectroscopie a fluorescence
WO1997034175A1 (fr) * 1996-03-13 1997-09-18 Visionex, Inc. Procede et appareil de gestion amelioree de la lumiere de fibres optiques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4988212A (en) * 1985-10-25 1991-01-29 Luxtron Corporation Fiberoptic sensing of temperature and/or other physical parameters
CA1253247A (fr) * 1986-04-03 1989-04-25 Gerald W. Farnell Camera d'imagerie a ultrasons utilisant des reseaux de guides d'ondes acoustiques

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5125404A (en) * 1985-03-22 1992-06-30 Massachusetts Institute Of Technology Apparatus and method for obtaining spectrally resolved spatial images of tissue
WO1996029926A1 (fr) * 1995-03-31 1996-10-03 The Board Of Regents, The University Of Texas System Sonde destinee a la detection des neoplasies cervicales au moyen de la spectroscopie a fluorescence
WO1997034175A1 (fr) * 1996-03-13 1997-09-18 Visionex, Inc. Procede et appareil de gestion amelioree de la lumiere de fibres optiques

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0057157A1 *

Also Published As

Publication number Publication date
EP1173746A4 (fr) 2008-04-23
AU3877600A (en) 2000-10-09
WO2000057157A8 (fr) 2001-03-15
WO2000057157A1 (fr) 2000-09-28

Similar Documents

Publication Publication Date Title
US6577391B1 (en) Apparatus and method for determining tissue characteristics
US7006220B2 (en) Apparatus and method for determining tissue characteristics
Mourant et al. Elastic scattering spectroscopy as a diagnostic tool for differentiating pathologies in the gastrointestinal tract: preliminary testing
US6975899B2 (en) Multi-modal optical tissue diagnostic system
Utzinger et al. Fiber optic probes for biomedical optical spectroscopy
US6507747B1 (en) Method and apparatus for concomitant structural and biochemical characterization of tissue
US7508524B2 (en) Combined raman spectroscopy-optical coherence tomography (RS-OCT) system and applications of the same
JP4217403B2 (ja) 組織病巣の特徴付けおよびマッピングのためのシステム
US6741884B1 (en) Infrared endoscopic balloon probes
Crow et al. Optical diagnostics in urology: current applications and future prospects.
US20060282009A1 (en) Device for measuring physical properties of the tympanic membrane
US20090326385A1 (en) Obtaining optical tissue properties
US20030135122A1 (en) Multi-modal optical tissue diagnostic system
US20120232408A1 (en) Method and Apparatus for Cervical Cancer Screening
WO2009157825A1 (fr) Procédé et dispositif pour diagnostiquer des pathologies auriculaires
EP1173746A1 (fr) Appareil et procede de determination des caracteristiques d'un tissu
CA2389177C (fr) Systeme multimodal optique de diagnostic tissulaire
WO2000013578A1 (fr) Sondes a ballonnet pour endoscope a infrarouge
Almond et al. Development of fibre-optic Raman probes for in vivo diagnosis of upper gastrointestinal cancers
MXPA01002554A (en) Multi-modal optical tissue diagnostic system

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011023

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20011023;LT PAYMENT 20011023;LV PAYMENT 20011023;MK PAYMENT 20011023;RO PAYMENT 20011023;SI PAYMENT 20011023

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SANDERS, WALTER, R.

Inventor name: FARQUHAR, DAVID

Inventor name: ARCHE, GLEN, STEVEN

Inventor name: BAMBOT, SHABBIR, B.

Inventor name: KIMBRELL, EDWARD, L.

Inventor name: HARRELL, TIM

Inventor name: FAUPEL, MARK, L.

A4 Supplementary search report drawn up and despatched

Effective date: 20080326

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 21/64 20060101ALI20080318BHEP

Ipc: G01N 21/00 20060101AFI20001003BHEP

Ipc: G01N 21/49 20060101ALI20080318BHEP

Ipc: G01N 21/25 20060101ALI20080318BHEP

Ipc: A61B 5/00 20060101ALI20080318BHEP

Ipc: G01N 21/47 20060101ALI20080318BHEP

17Q First examination report despatched

Effective date: 20080918

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090331